821 F.Supp.2d 591 (S.D.N.Y. 2011), 04-MD-1603 (SHS), In re Oxycontin Antitrust Litigation
Linked as:
Extract
821 F.Supp.2d 591 (S.D.N.Y. 2011), 04-MD-1603 (SHS), In re Oxycontin Antitrust Litigation
No longer available (Autolink)
See the full content of this document
This document cites
- Federal Cases - 932 F.2d 1043 (2nd Cir. 1991), 932, Somlyo v. J. Lu-Rob Enterprises, Inc.
- Federal Cases - 991 F.2d 36 (2nd Cir. 1993), 1023, Menowitz v. Brown
- Federal Cases - 996 F.2d 1425 (2nd Cir. 1993), 670, In re Agent Orange Product Liability Litigation
- Federal Cases - 287 F.3d 110 (2nd Cir. 2002), 00-7986, Connecticut v. Physicians Health Services Of Connecticut, Inc.
- Federal Cases - 335 F.3d 109 (2nd Cir. 2003), 02-9141, Vera v. Saks & Co.